HomeKTTA • NASDAQ
Pasithea Therapeutics Corp
add
$0.72
3.84%
Pre-market:(0.54%)+0.0039
$0.72
Closed: Jun 24, 4:00:02 AM UTC-4 · USD · NASDAQ · Disclaimer
Market news
Financials
Income Statement
Revenue
Net Income
Revenue
Net income
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 3.68M | -8.94% |
Net income | -3.56M | 7.71% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | -3.52M | 9.30% |
Effective tax rate | — | — |
Balance Sheet
Total Assets
Total Liabilities
Total assets
Total liabilities
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 5.34M | -55.52% |
Total assets | 14.66M | -34.58% |
Total liabilities | 1.68M | -33.45% |
Total equity | 12.98M | — |
Shares outstanding | 7.44M | — |
Price to book | 0.16 | — |
Return on assets | -59.88% | — |
Return on capital | -66.27% | — |
Cash Flow
Net Change in Cash
Net change in cash
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | -3.56M | 7.71% |
Cash from operations | -3.06M | 29.28% |
Cash from investing | — | — |
Cash from financing | 1.47M | — |
Net change in cash | -1.58M | 63.41% |
Free cash flow | -1.90M | 35.67% |
Previous close
$0.75
Day range
$0.71 - $0.73
Year range
$0.71 - $7.49
Market cap
5.34M USD
Avg Volume
1.70M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
About
Founded
2020
Headquarters
Website
Employees
4
